To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Podcast: Listen
OncLive Elisabeth Heath, M.D., FACP , medical oncologist, leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at Karmanos, is featured on OncLive Insights and interviewed by Tanya Dorff, M.D. of City of Hope. Dr. Heath discusses a number of topics during this multi-series interview surrounding the current treatment and clinical trials for metastatic castration-resistant prostate cancer. Episode 1: Overview on Metastic CRPC and Available T...
PHEN TV Elisabeth Heath, M.D., FACP , medical oncologist, leader of the Genitourinary Oncology Multidisciplinary Team at Karmanos, associate center director for Translational Science, Hartmann Endowed Chair for Prostate Cancer Research and professor of oncology at Wayne State University’s School of Medicine, presented "Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions," at the Prostate Health Education Network's 18th Annual African America...
Elisabeth Heath, M.D., FACP , leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at the Barbara Ann Karmanos Cancer Institute, has received grant renewal from the U.S. Department of Defense to continue membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. The Prostate Cancer Clinical Consortium Award is a peer-reviewed, competitive grant. Peers include scientific researchers at universities and cancer center...
In this episode, Dr. Elisabeth Heath from Karmanos Cancer Institute discusses what advocates mean for her and her colleagues who work at Karmanos.
As a National Cancer Institute Comprehensive Cancer Center, Karmanos has redefined cancer care.
Genitourinary cancer is a term you might not be familiar with, but the disease it includes you most certainly are including prostate cancer, kidney, and bladder cancer as well.